Stocks
PMV Pharmaceuticals, Inc.PMVP
NASDAQHealthcareBiotechnology$1.24
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing small molecule drugs that target p53, a key tumor suppressor protein mutated in many cancers. Its lead candidate, rezatapopt, is in mid-stage trials for solid tumors with specific p53 mutations. Investors track the company for its position in the emerging field of p53 reactivation therapies.
52W Range: $1.02-$1.91
Congressional Interest in PMV Pharmaceuticals, Inc. (PMVP)
No congressional trades have been disclosed for PMV Pharmaceuticals, Inc. (PMVP) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PMVP?
No congressional trades found for this stock.